Triple-compartment strategy for abdominal sacral colpopexy using PVDF mesh: one-year report of anatomical and subjective outcomes.


Journal

International urogynecology journal
ISSN: 1433-3023
Titre abrégé: Int Urogynecol J
Pays: England
ID NLM: 101567041

Informations de publication

Date de publication:
08 2023
Historique:
received: 04 09 2022
accepted: 08 01 2023
medline: 11 8 2023
pubmed: 17 2 2023
entrez: 16 2 2023
Statut: ppublish

Résumé

Abdominal Sacral Colpopexy (ASC) is one of the best surgical methods to repair apical or uterine prolapse. We aimed to evaluate the short-term results of a triple-compartment open ASC strategy using polyvinylidene fluoride (PVDF) mesh in the treatment of patients with severe apical or uterine prolapse. Women with high-grade uterine or apical prolapse with or without cysto-rectocele were prospectively enrolled in the study from April 2015 to June 2021. We performed all-compartment repair using a tailored PVDF mesh for ASC. We assessed the severity of pelvic organ prolapse (POP) using the Pelvic Organ Prolapse Quantification (POP-Q) system at baseline and 12 months after the operation. The patients completed the International Continence Society Questionnaire Vaginal Symptom (ICIQ-VS) questionnaire at baseline, 3, 6, and 12 months postoperatively. Thirty-five women with a mean age of 59.8±10.0 years were included in the final analysis. Stage III and stage IV prolapse was evident in 12 and 25 patients, respectively. After 12 months, the median POP-Q stage was significantly lower compared to the baseline (4 vs 0, p=<0.0001). Vaginal symptoms score was also reduced significantly at 3-month (7.5±3.5), 6-month (7.3±3.6), and 12-month (7.2±3.1) compared to the baseline (39.5±6.7) (p values < 0.0001). We did not observe any mesh extrusion or high-grade complications. Six (16.7%) patients had cystocele recurrence during the 12-month follow-up, and two of them needed reoperation. Our short-term follow-up showed that using an open ASC technique with PVDF mesh in treating high-grade apical or uterine prolapse is associated with a high rate of procedural success and low rates of complication.

Identifiants

pubmed: 36795111
doi: 10.1007/s00192-023-05471-y
pii: 10.1007/s00192-023-05471-y
doi:

Substances chimiques

polyvinylidene fluoride 24937-79-9

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1907-1914

Informations de copyright

© 2023. The International Urogynecological Association.

Références

Haylen BT, De Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodynam: Off J Int Continence Soc. 2010;29(1):4–20.
doi: 10.1002/nau.20798
Coolen A-LW, Bui BN, Dietz V, Wang R, van Montfoort AP, Mol BWJ, Roovers J-PW, Bongers MY. The treatment of post-hysterectomy vaginal vault prolapse: a systematic review and meta-analysis. Int Urogynecol J. 2017;28(12):1767.
Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A. Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. Am J Obstet Gynecol. 2002;186(6):1160–6.
Maher C, Feiner B, Baessler K, Glazener CM. Surgical management of pelvic organ prolapse in women. Cochrane Database Syst Rev. 2010;(4).
Vahdatpour B, Zargham M, Chatraei M, Bahrami F, Alizadeh F. Potential risk factors associated with stress urinary incontinence among Iranian women. Adv Biomed Res.  2015;4:205.
Nygaard I, Bradley C, Brandt D, WsH I. Pelvic organ prolapse in older women: prevalence and risk factors. Obstet Gynecol. 2004;104(3):489–97.
doi: 10.1097/01.AOG.0000136100.10818.d8 pubmed: 15339758
Maher C, Feiner B, Baessler K, Christmann-Schmid C, Haya N, Brown J. Surgery for women with apical vaginal prolapse. Cochrane Database System Rev. 2016;(10):CD012376.
Vergeldt TF, Weemhoff M, IntHout J, Kluivers KB. Risk factors for pelvic organ prolapse and its recurrence: a systematic review. Int Urogynecol J. 2015;26(11):1559.
doi: 10.1007/s00192-015-2695-8 pubmed: 25966804 pmcid: 4611001
Smith FJ, Holman CDAJ, Moorin RE, Tsokos N. Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet Gynecol. 2010;116(5):1096–100.
doi: 10.1097/AOG.0b013e3181f73729 pubmed: 20966694
Funk MM, Edenfield AL, Pate MV, Visco AV, Weidner AC. Trends in use of surgical mesh for pelvic organ prolapse. Am J Obstet Gynecol. 2013;208(1):79.e71.
Barber MD, Maher C. Apical Prolapse Int Urogynecol J. 2013;24(11):1815–33.
doi: 10.1007/s00192-013-2172-1 pubmed: 24142057
Akyol A, Akca A, Ulker V, Gedikbasi A, Kublay A, Han A, Ark HC, Numanoglu C. Additional surgical risk factors and patient characteristics for mesh erosion after abdominal sacrocolpopexy. J Obstet Gynaecol Res. 2014;40(5):1368–74.
doi: 10.1111/jog.12363 pubmed: 24754851
Nygaard I, Brubaker L, Zyczynski HM, Cundiff G, Richter H, Gantz M, Fine P, Menefee S, Ridgeway B, Visco A. Long-term outcomes following abdominal sacrocolpopexy for pelvic organ prolapse. JAMA. 2013;309(19):2016–24.
doi: 10.1001/jama.2013.4919 pubmed: 23677313 pmcid: 3747840
Thys S, Hakvoort R, Milani A, Roovers JP, Vollebregt A. Can we predict continued pessary use as primary treatment in women with symptomatic pelvic organ prolapse (POP)? A prospective cohort study. Int Urogynecol J. 2021;32(8):2159–67.
doi: 10.1007/s00192-021-04817-8 pubmed: 34002267
Noé K-G, Schiermeier S, Alkatout I, Anapolski M. Laparoscopic pectopexy: a prospective, randomized, comparative clinical trial of standard laparoscopic sacral colpocervicopexy with the new laparoscopic pectopexy-postoperative results and intermediate-term follow-up in a pilot study. J Endourol. 2015;29(2):210–5.
doi: 10.1089/end.2014.0413 pubmed: 25350228 pmcid: 4313410
Balsamo R, Illiano E, Zucchi A, Natale F, Carbone A, De Sio M, Costantini E. Sacrocolpopexy with polyvinylidene fluoride mesh for pelvic organ prolapse: Mid term comparative outcomes with polypropylene mesh. Eur J Obstet Gynecol Reprod Biol. 2018;220:74–8.
doi: 10.1016/j.ejogrb.2017.11.018 pubmed: 29175131
Callewaert G, Housmans S, Cattani L, Pacquée S, D'Hoore A, Wyndaele J, Van der Aa F, Deprest J. Medium-term outcome of laparoscopic sacrocolpopexy using polivinylidene fluoride as compared to a hybrid polyglecaprone and polypropylene mesh: A matched control study. Neurourol Urodyn. 2019;38(7):1874–82.
doi: 10.1002/nau.24083 pubmed: 31290173
Rajshekhar S, Mukhopadhyay S, Morris E. Early safety and efficacy outcomes of a novel technique of sacrocolpopexy for the treatment of apical prolapse. Int J Gynaecol Obstet: Off Organ Int Federation Gynaecol Obstet. 2016;135(2):182–6.
doi: 10.1016/j.ijgo.2016.05.007
Kavallaris A, Zygouris D. Laparoscopic sacrocolpopexy comparing polypropylene mesh with polyvinylidene fluoride mesh for pelvic organ prolapse: Technique description and long term outcomes. Neurourol Urodyn. 2020;39(8):2264–71.
doi: 10.1002/nau.24480 pubmed: 32776608
de Castro EB, Brito LGO, Juliato CRT. Vaginal hysterectomy with bilateral sacrospinous fixation plus an anterior mesh versus abdominal sacrocervicopexy for the treatment of primary apical prolapse in postmenopausal women: a randomized controlled study. Int Urogynecol J. 2020;31(2):365–72.
doi: 10.1007/s00192-019-03948-3 pubmed: 31028421
Cassis C, Mukhopadhyay S, Morris E. Standardizing abdominal sacrocolpopexy for the treatment of apical prolapse: One year on. Int J Gynaecol Obstet: Off Organ Int Federation Gynaecol Obstet. 2019;147(1):49–53.
doi: 10.1002/ijgo.12935
Persu C, Chapple C, Cauni V, Gutue S, Geavlete P. Pelvic Organ Prolapse Quantification System (POP–Q)–a new era in pelvic prolapse staging. J Med Life. 2011;4(1):75.
pubmed: 21505577 pmcid: 3056425
Pourmomeny AA, Foolad F, Sedighmehr N, Zargham M, Sharifiaghdas F. Translation and linguistic validation of the Persian version of the International consultation on Incontinence Questionnaire Vaginal Symptoms. J Res Med Sci: Off J Isfahan Univ Med Sci.  2021;26:58.
Gerullis H, Klosterhalfen B, Borós M, Lammers B, Eimer C, Georgas E, Otto T. IDEAL in meshes for prolapse, urinary incontinence, and hernia repair. Surg Innov. 2013;20(5):502–8.
doi: 10.1177/1553350612472987 pubmed: 23339146
Müllen A, Göretzlehner U. PVDF als Implantat-Werkstoff in der Urogynäkologie. Biomaterialien. 2007;8(S1):28–9.
Noé K, Spüntrup C, Anapolski M. Laparoscopic pectopexy: a randomised comparative clinical trial of standard laparoscopic sacral colpo-cervicopexy to the new laparoscopic pectopexy. Short-term postoperative results. Arch Gynecol Obstet. 2013;287(2):275–80.
doi: 10.1007/s00404-012-2536-7 pubmed: 22945837
Barski D, Arndt C, Gerullis H, Yang J, Boros M, Otto T, Kolberg H-C. Transvaginal PVDF-mesh for cystocele repair: A cohort study. Int J Surg (London, England). 2017;39:249–54.
doi: 10.1016/j.ijsu.2017.02.006
Eslami M-J, Zargham M, Gholipour F, Hajian M, Bakhtiari K, Hajebrahimi S, Eghbal M, Farajzadegan Z. Transvaginal repair of anterior vaginal wall prolapse with polyvinylidene fluoride (PVDF) mesh: an alternative for previously restricted materials? Int Urogynecol J. 2022 ;33:1989–97.
Bojahr B, Tchartchian G, Waldschmidt M, Schollmeyer T, De Wilde RL. Laparoscopic sacropexy: a retrospective analysis of perioperative complications and anatomical outcomes. JSLS: J Soc Laparoendoscopic Surg. 2012;16(3):428.
doi: 10.4293/108680812X13462882736132
Orhan A, Ozerkan K, Vuruskan H, Ocakoglu G, Kasapoglu I, Koşan B, Uncu G. Long-term follow-up of laparoscopic sacrocolpopexy: comparison of two different techniques used in urology and gynecology. Int Urogynecol J. 2019;30(4):623–32.
doi: 10.1007/s00192-018-03858-w pubmed: 30627828
Clark AL, Gregory T, Smith VJ, Edwards R. Epidemiologic evaluation of reoperation for surgically treated pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol. 2003;189(5):1261–7.
doi: 10.1067/S0002-9378(03)00829-9 pubmed: 14634551
Coolen A-LW, van Oudheusden AM, Mol BWJ, van Eijndhoven HW, Roovers J-PW, Bongers MY. Laparoscopic sacrocolpopexy compared with open abdominal sacrocolpopexy for vault prolapse repair: a randomised controlled trial. Int Urogynecol J. 2017;28(10):1469.
doi: 10.1007/s00192-017-3296-5 pubmed: 28417153 pmcid: 5606943
Stepanian AA, Miklos JR, Moore RD, Mattox TF. Risk of mesh extrusion and other mesh-related complications after laparoscopic sacral colpopexy with or without concurrent laparoscopic-assisted vaginal hysterectomy: experience of 402 patients. J Minim Invasive Gynecol. 2008;15(2):188–96.
doi: 10.1016/j.jmig.2007.11.006 pubmed: 18312989
Nightingale G, Phillips C. Long-term safety and efficacy of laparoscopically placed mesh for apical prolapse. Int Urogynecol J. 2021;32(4):871–7.
doi: 10.1007/s00192-020-04374-6 pubmed: 32524157

Auteurs

Mahtab Zargham (M)

Department of Urology, Isfahan University of Medical Sciences, Al-Zahra Hospital, Soffeh Blvd., Isfahan, Iran. mah_zargham@yahoo.com.

Mehdi Dehghani (M)

Department of Urology, Isfahan University of Medical Sciences, Al-Zahra Hospital, Soffeh Blvd., Isfahan, Iran. m.dehghani@med.mui.ac.ir.

Farshad Gholipour (F)

Isfahan Kidney Disease Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Maryam Emami (M)

Department of Urology, Iran University of Medical Sciences, Tehran, Iran.

Maziar Daneshvari (M)

Department of Urology, Isfahan University of Medical Sciences, Al-Zahra Hospital, Soffeh Blvd., Isfahan, Iran.

Alireza Aminsharifi (A)

Division of Urology, Duke University Hospital, Durham, NC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH